Mark P. Arrington Ph. D.

Mark P. Arrington Ph. D.

Magleby Cataxinos

Intellectual Property & Other Complex Litigation Lawyers in Salt Lake City, UT in Salt Lake City, UT

Salt Lake City, UT866-928-7962
Intellectual Property & Other Complex LitigationOpinionsPatentsTrademarks & CopyrightsCounseling & Strategic PlanningDue Diligence

About Mark P. Arrington Ph. D.

Dr. Arrington, received his J.D. from University of Utah, S.J. Quinney College of Law, with honors. During law school, Dr. Arrington received the CALI award for the highest grade in Patent Law, and was a member of the University of Utah National Intellectual Property Moot Court team. He holds a Ph.D. in Organic Chemistry from Colorado State University and a Bachelor of Science in Chemistry from UC San Diego. Prior to attending law school, Dr. Arrington served as a medicinal chemist for 10 years, pursuing drug discovery research in therapeutic areas including Allergy/Inflammation, Oncology, and Neuroscience. Experience and Expertise Metallurgy; Neuroscience; Pharmaceutical & process chemistry; Polymer materials and polymer processing techniques; Semiconductor device fabrication, packaging and assembly;

Education

Legal Education

  • The S.J. Quinney College of Law at The University of Utah, Salt Lake City, Utah
  • J.D.
  • Honors: CALIAward

Non Legal Education

  • Colorado State University, Fort Collins, Colorado
  • Ph. D.
  • Major: Organic Chemistry
  • UC San Diego
  • B.S., Bachelor of Science
  • Major: Chemistry
  • The Ohio State University
  • Eli-Lilly Post Doctorate Fellow

Past Positions

  • TraskBritt, Patent Attorney/Agent
  • Kalexsyn, Inc., Senior Scientist
  • Memory Pharmaceuticals Corp., Staff Scientist - Medicinal Chemistry
  • Array Biopharma, Inc., Research Scientist - Custom Synthesis
  • UCB Research, Inc., Senior Scientist II

Published Works

Articles

  • Cinnoline Derivatives as phosphodiesterase 10 inhibitors, their preparation, pharmaceutical compositions, and use in therapy , WO2007098169 , 2007
  • Cetirizine and loratadine-based antihistamines with 5-lipoxygenase inhibitory activity. [Bioorg. Med. Chem. Lett., 14(22): 5591-5594], 2004
  • Constraining of Small-Ring Cyclic Ether Triads by Stereodefined Spiroannulation to an Inositol Orthoformate Platform. Solution-and Gas-Phase Alkali Metal Binding Affinities for Three-to-Five-Membered Ring Structural Combinations. [J. Org. Chem. 66(25): 8629-8639], 2001
  • Enantioselective double michael addition/cyclization with an oxygen-centered nucleophile as the first step in a concise synthesis of natural (+)-asteriscanolide. [J. Am. Chem. Soc. 122(12): 2742-2748], 2000
  • Asymmetric Synthesis of the Core Cyclopentane of Viridenomycin. [Chem. Comm., 15.1371-1372], 1999
  • Modified cinchona alkaloid ligands: Improved selectivities in the osmium tetroxide catalyzed asymmetric dihydroxylation (AD) of terminal olefins. [Tetrahedron Lett. 34(46): 7375-7378], 1993
  • Synthesis and preliminary evaluation of aryl arenesulfonate esters as potential intermediate temperature fluids [Indus. & Eng. Chem. Res. 34(3): 981-986], 1995

Bar Admissions

  • U.S. Patent and Trademark Office

Other Affiliations

  • University of Utah National Intellectual Property Moot Court team

Attorney Details

Full NameMark P. Arrington Ph. D.
FirmMagleby Cataxinos
Address141 W. Pierpont Ave., Salt Lake City, UT 84101
Phone866-928-7962
Phone801-359-9011
New Clients Currently accepting